HepatitisB
Next-Level Clinical Practice, Real-World Impact: Evolving Patient Simulation with the Clinical Readiness Studio
Healthcare is changing rapidly, bringing unprecedented data and complex treatment pathways to the point of care. Clinical mastery requires active experience, the confidence to make decisions when real patient outcomes...
From Booth to Bavaria: A Recap of Impact at ESC 2026
We have officially wrapped up another year at ESC. For Medscape Education, 4 days on the ground confirmed what 3 decades of cardiovascular education have already shown: when independent, evidence-based...
The Heart of the Matter: Medscape Education’s Cardiology Footprint at ESC 2026
For more than 30 years, Medscape Education has built independent, accredited cardiovascular education designed around one goal: improved patient outcomes. This year at the European Society of Cardiology Congress (ESC...
Gilead’s New Drug Application for Yeztugo accepted by US FDA
The investigational once-weekly oral treatment could be the first long-acting pill for HIV prevention
From ‘why’ to ‘how’: patient partnership across age groups in research and publications
By Sarah Mohamad
Medscape Wins Anthem Award for Rare Disease Education Platform
Platform has reached 2.4 million healthcare professionals worldwide since 2021. Newark, NJ - [November 18, 2025] - Medscape, the leading digital platform for physicians and healthcare professionals (HCPs), has been...
Innovation in Action at AAFP FMX 2025
This year, Medscape Education is redefining the live learning experience at AAFP FMX 2025. With 8 groundbreaking, accredited symposia, we are proud to be at the heart of the meeting,...
Global Healthy Living Foundation and Medscape Education Join Forces to Bridge the Gap Between Patients and Providers with Immunology Education
UPPER NYACK, N.Y.--(BUSINESS WIRE)--The Global Healthy Living Foundation (GHLF) today announced a new partnership with Medscape Education to advance patient-centered innovation within the Immunology Learning Nexus (Nexus), Medscape’s flagship multi-year...
Gilead Sciences’ Biktarvy granted FDA approval for expanded HIV use
An estimated 1.2 million people in the US are currently living with the virus
Medical Misinformation and Sensationalism in the Age of Social Media
In today’s digital age, misinformation spreads faster than ever, often driven by sensational headlines and influencer content. These sources of misinformation often overshadow evidence-based content, creating confusion for both healthcare...
Gilead Sciences’ twice-yearly HIV PrEP drug Yeztugo granted FDA approval
More than 100 people in the US were diagnosed with HIV every day in 2023
Driving Impact in Diabetes Care: Medscape to Present 11 Publications at ADA’s 85th Scientific Sessions
Medscape Education is proud to present 11 publications at the American Diabetes Association 85th Scientific Sessions, taking place June 20–23 in Chicago. These presentations reflect our commitment to advancing diabetes care...